- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for per
KA Stock Earnings: Kineta Misses EPS for Q1 2024
KA stock results show that Kineta missed analyst estimates for earnings per share the first quarter of 2024.
RZLT Stock Earnings: Rezolute Misses EPS for Q3 2024
RZLT stock results show that Rezolute missed analyst estimates for earnings per share the third quarter of 2024.
RWEOY Stock Earnings: RWE Beats EPS for Q1 2024
RWEOY stock results show that RWE beat analyst estimates for earnings per share the first quarter of 2024.
LGO Stock Earnings: Largo Misses EPS for Q1 2024
LGO stock results show that Largo missed analyst estimates for earnings per share the first quarter of 2024.
PET Stock Earnings: Wag Group Meets EPS, Beats Revenue for Q1 2024
PET stock results show that Wag Group met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
COYA Stock Earnings: Coya Therapeutics Misses EPS for Q1 2024
COYA stock results show that Coya Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024
PRME stock results show that Prime Medicine beat analyst estimates for earnings per share the first quarter of 2024.
ONDS Stock Earnings: Ondas Holdings Meets EPS for Q1 2024
ONDS stock results show that Ondas Holdings met analyst estimates for earnings per share the first quarter of 2024.
CATX Stock Earnings: Perspective Therapeutics Meets EPS for Q1 2024
CATX stock results show that Perspective Therapeutics met analyst estimates for earnings per share the first quarter of 2024.
GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024
GUTS stock results show that Fractyl Health beat analyst estimates for earnings per share the first quarter of 2024.
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024
UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
APRE Stock Earnings: Aprea Therapeutics Beats EPS for Q1 2024
APRE stock results show that Aprea Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
MAG Stock Earnings: MAG Silver Beats EPS for Q1 2024
MAG stock results show that MAG Silver beat analyst estimates for earnings per share the first quarter of 2024.
CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q1 2024
CYCC stock results show that Cyclacel Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
TCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024
TCON stock results show that TRACON Pharma missed analyst estimates for earnings per share the first quarter of 2024.
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024
BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
SCWO Stock Earnings: 374Water Meets EPS for Q1 2024
SCWO stock results show that 374Water met analyst estimates for earnings per share the first quarter of 2024.
NTBL Stock Earnings: Notable Labs Misses EPS for Q1 2024
NTBL stock results show that Notable Labs missed analyst estimates for earnings per share the first quarter of 2024.
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
SPRY Stock Earnings: ARS Pharmaceuticals Meets EPS for Q1 2024
SPRY stock results show that ARS Pharmaceuticals met analyst estimates for earnings per share the first quarter of 2024.
ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024
ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the second quarter of 2024.
ADVM Stock Earnings: Adverum Biotechnologies Misses EPS for Q1 2024
ADVM stock results show that Adverum Biotechnologies missed analyst estimates for earnings per share the first quarter of 2024.
HLVX Stock Earnings: HilleVax Misses EPS for Q1 2024
HLVX stock results show that HilleVax missed analyst estimates for earnings per share the first quarter of 2024.
2 – 10 of 240 results
